Which organization developed the ICH E6(R3) Guideline?

• A. World Health Organization
• B. U.S. Food and Drug Administration
• C. The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)
• D. International Council on Pharmaceutical Standardization

Answer: (C)

The guideline was developed by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, known as ICH. This organization brings together regulatory authorities from Europe, the United States, and Japan with industry representatives to create harmonized standards for pharmaceutical development and trial conduct. The E6 guideline, which covers Good Clinical Practice, is one of the ICH’s flagship standards, and its revision to R3 reflects ongoing updates to align with current practices in trial design, data management, and ethics. The World Health Organization and the U.S. FDA participate in ICH activities, but the guideline itself is produced by ICH, not by those bodies individually.